Skip to main content
Top
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Research

A clinicopathological study about the epidemiology of granulosa cell tumors in Lebanon

Authors: Sana Yaacoub, Labib Hajj, Aya Khairallah

Published in: BMC Cancer | Issue 1/2024

Login to get access

Abstract

Background

Granulosa Cell Tumors (GCT) are considered the most frequent type of sex-cord stromal tumors. These tumors constitute 3-6% of neoplasms of the ovaries. GCTs are divided into 2 types: Juvenile GCT (JGCT) and Adult GCT (AGCT). Most patients are diagnosed early in the course of the disease and tend to have a favorable prognosis. In the surgical treatment of GCT, two main factors play role in the determination of feasibility of the surgery: age and tumor stage.

Methods

A retrospective study was conducted on 65 consecutive female patients diagnosed with ovarian GCT at different hospitals across Lebanon who were referred to the National Institute of Pathology, Beirut-Lebanon, between January 2000 and January 2020. Then, they were divided according to types: adult versus juvenile type. Statistical analysis was carried out using Stata, version 16.

Results

The incidence of GCT in a Lebanese population was 16.2 per million per year. The mean age of the studied population was 55.6 years. AGCT was the most common with a prevalence of 91% versus 19% for JGCT. Also, inhibine (the most important immunomarker) was found in 77.2% of adult cases. High mitotic index and high tumor size which are predictors for poor prognosis were respectively 20% and 36.9%. Concerning the histopathological features, Grooved nuclei and Exner bodies were less frequently observed in juvenile type (16.7% for both) compared to adult type (36.9%). Most patients with GCT were diagnosed in the early course of disease mainly due to the manifestation of the symptoms as abdominal pain, postmenopausal bleeding or intermenstrual bleeding, and the good diagnosis and screening practices in Lebanon. Regarding the recurrent cases, a significant correlation with high mitotic index (76.9%), high tumor size (92.3%) and advanced stage (46% for stage 3 and 46% for stage 4) was found with a p < 0.05.

Conclusions

The incidence of GCT in the Lebanese population is 16.2 per million per year. The majority of patients with GCT in Lebanon are of Adult type representing around 90% of cases. Older age, high mitotic index and big tumor size are predictors for poor outcomes.
Literature
1.
go back to reference Dridi M, Chraiet N, Batti R, Ayadi M, Mokrani A, Meddeb K, Yahiaoui Y, Raies H, Mezlini A. Granulosa Cell Tumor of the Ovary: A Retrospective Study of 31 Cases and a Review of the Literature. Int J SurgOncol. 2018;2018:4547892. https://doi.org/10.1155/2018/4547892. PMID: 29796312. https://doi.org/10.1155/2018/4547892. Dridi M, Chraiet N, Batti R, Ayadi M, Mokrani A, Meddeb K, Yahiaoui Y, Raies H, Mezlini A. Granulosa Cell Tumor of the Ovary: A Retrospective Study of 31 Cases and a Review of the Literature. Int J SurgOncol. 2018;2018:4547892. https://​doi.​org/​10.​1155/​2018/​4547892. PMID: 29796312. https://​doi.​org/​10.​1155/​2018/​4547892.​
5.
go back to reference Jamieson S, Fuller PJ. Molecular pathogenesis of granulosa cell tumors of the ovary. Endocr Rev. 2012;33(1):109– 44. https://doi.org/10.1210/er.2011-0014. PMID: 22240241. https://doi.org/10.1210/er.2011-0014. Jamieson S, Fuller PJ. Molecular pathogenesis of granulosa cell tumors of the ovary. Endocr Rev. 2012;33(1):109– 44. https://​doi.​org/​10.​1210/​er.​2011-0014. PMID: 22240241. https://​doi.​org/​10.​1210/​er.​2011-0014.​
6.
go back to reference Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21(6):1180-9. https://doi.org/10.1200/JCO.2003.10.019. PMID: 12637488. https://ascopubs.org/doi/10.1200/JCO.2003.10.019. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21(6):1180-9. https://​doi.​org/​10.​1200/​JCO.​2003.​10.​019. PMID: 12637488. https://​ascopubs.​org/​doi/​10.​1200/​JCO.​2003.​10.​019.​
7.
go back to reference Guleria P, Kumar L, Kumar S, Bhatla N, Ray R, Singhal S, et al. A clinicopathological study of granulosa cell tumors of the ovary: can morphology predict prognosis? Indian J Pathol Microbiol. 2020;63(1):53–9. http://www.ijpmonline.org/article..asp?issn=0377-4929;year=2020;volume=63;issue=1;spage=53;epage=59;aulast=Guleria. doi: 10.4103/IJPM.IJPM_403_19. PMID.CrossRefPubMed Guleria P, Kumar L, Kumar S, Bhatla N, Ray R, Singhal S, et al. A clinicopathological study of granulosa cell tumors of the ovary: can morphology predict prognosis? Indian J Pathol Microbiol. 2020;63(1):53–9. http://​www.​ijpmonline.​org/​article..asp?issn=0377-4929;year=2020;volume=63;issue=1;spage=53;epage=59;aulast=Guleria. doi: 10.4103/IJPM.IJPM_403_19. PMID.CrossRefPubMed
14.
go back to reference Kattan J, Droz JP, Culine S, Duvillard P, Thiellet A, Peillon C. The growing teratoma syndrome: a woman with nonseminomatous germ cell tumor of the ovary. GynecolOncol. 1993;49(3):395-9. https://doi.org/10.1006/gyno.1993.1147. PMID: 8314544. https://doi.org/10.1006/gyno.1993.1147. Kattan J, Droz JP, Culine S, Duvillard P, Thiellet A, Peillon C. The growing teratoma syndrome: a woman with nonseminomatous germ cell tumor of the ovary. GynecolOncol. 1993;49(3):395-9. https://​doi.​org/​10.​1006/​gyno.​1993.​1147. PMID: 8314544. https://​doi.​org/​10.​1006/​gyno.​1993.​1147.​
16.
go back to reference Babarović E, Franin I, Klarić M, Ferrari AM, Karnjuš-Begonja R, Eminović S et al. Adult granulosa cell tumors of the ovary: a retrospective study of 36 FIGO stage I cases with emphasis on prognostic pathohistological features. Anal Cell Pathol (Amst). 2018;2018:9148124. https://doi.org/10.1155/2018/9148124. PMID: 30186737. https://doi.org/10.1155/2018/9148124. Babarović E, Franin I, Klarić M, Ferrari AM, Karnjuš-Begonja R, Eminović S et al. Adult granulosa cell tumors of the ovary: a retrospective study of 36 FIGO stage I cases with emphasis on prognostic pathohistological features. Anal Cell Pathol (Amst). 2018;2018:9148124. https://​doi.​org/​10.​1155/​2018/​9148124. PMID: 30186737. https://​doi.​org/​10.​1155/​2018/​9148124.​
17.
go back to reference Bryk S, Pukkala E, Martinsen JI, Unkila-Kallio L, Tryggvadottir L, Sparén P et al. Incidence and occupational variation of ovarian granulosa cell tumours in Finland, Iceland, Norway and Sweden during 1953–2012: a longitudinal cohort study. BJOG. 2017;124(1):143-9. https://doi.org/10.1111/1471-0528.13949. PMID: 26924812. https://doi.org/10.1111/1471-0528.13949. Bryk S, Pukkala E, Martinsen JI, Unkila-Kallio L, Tryggvadottir L, Sparén P et al. Incidence and occupational variation of ovarian granulosa cell tumours in Finland, Iceland, Norway and Sweden during 1953–2012: a longitudinal cohort study. BJOG. 2017;124(1):143-9. https://​doi.​org/​10.​1111/​1471-0528.​13949. PMID: 26924812. https://​doi.​org/​10.​1111/​1471-0528.​13949.​
18.
go back to reference Ud Din N, Kayani N. Recurrence of adult granulosa cell tumor of the ovary: experience at a tertiary care center. Ann Diagn Pathol. 2014;18(3):125-8. https://doi.org/10.1016/j.anndiagpath.2014.02.002. PMID: 24630126. https://doi.org/10.1016/j.anndiagpath.2014.02.002. Ud Din N, Kayani N. Recurrence of adult granulosa cell tumor of the ovary: experience at a tertiary care center. Ann Diagn Pathol. 2014;18(3):125-8. https://​doi.​org/​10.​1016/​j.​anndiagpath.​2014.​02.​002. PMID: 24630126. https://​doi.​org/​10.​1016/​j.​anndiagpath.​2014.​02.​002.​
Metadata
Title
A clinicopathological study about the epidemiology of granulosa cell tumors in Lebanon
Authors
Sana Yaacoub
Labib Hajj
Aya Khairallah
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-024-12047-6

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine